US Scientists’ Letter Calls for Transparency in Animal Research

Nearly 600 signatories, including four Nobel Prize winners, urge openness about animal experiments.

Written byAshley Yeager
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In a letter published online yesterday (June 20) in USA Today, 592 members of the scientific community called for research institutions to be transparent about their animal studies.

“We should proudly explain how animals are used for the advancement of science and medicine, in the interest of the wellbeing of humans and animals,” the signatories write, noting the work influences surgery, drug development, and basic research.

Such animal studies rely on public support and public funding, which is why the scientists are calling for transparency, according to the letter. Students, lab technicians, veterinarians, physicians, and public policy experts, along with scientists—including Nobel Prize winners William Campbell, Mario Capecchi, Carol Greider, and Torsten Wiesel—signed the letter, according to Science.

“I read the letter and decided within minutes that I would sign it,” Greider, a Johns Hopkins University School of Medicine biologist and 2009 Nobel laureate, tells Science. “Animal research is very ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies